Quoin Pharmaceuticals Reports Q3 GAAP EPS of -$0.97 and Net Loss of $4.9 Million
Quoin Pharmaceuticals (NASDAQ: QNRX) has released its third-quarter financial results, reporting a GAAP earnings per share (EPS) of -$0.97. The company recorded a net loss of approximately $4.9 million for the quarter, representing an increase in losses compared to the ~$3.9 million reported during the same period in the previous year. As of September 30, 2026, Quoin Pharmaceuticals maintained a liquidity position consisting of approximately $33.2 million in cash, cash equivalents, and marketable securities. The widening net loss suggests increasing operational expenses or costs associated with its current development stage.
Tickers: $QNRX
Topics: cash position earnings net loss
Read the full article at Seeking Alpha
Part of the story St. Joe Reports Q3 GAAP EPS of $0.65 and Revenue of $156.2 Million (30 articles)